Patients with staghorn renal stones are challenging cases, requiring careful preoperative
evaluation and close follow-up to avoid stone recurrence. In this article we aim to discuss the …

Introduction: We performed a systematic review and meta-analysis of the current literature to
assess the efficacy and safety of tranexamic acid (TXA) in the management of postoperative …

Objectives To assess the efficacy and safety of single‐dose tranexamic acid on the blood
transfusion rate and outcomes of patients with complex kidney stones undergoing …

Purpose: We performed a systematic review and meta-analysis of the literature to evaluate
the efficacy of the routine use of tranexamic acid (TXA) during percutaneous …

Background Percutaneous nephrolithotomy (PCNL) is the gold standard for the treatment of
large kidney stones but comes with an increased risk of bleeding compared to other …

Results Eight studies were included with a total 1,201 patients, of which 598 received TXA
and 603 received placebo. TXA was associated with less bleeding (decreased change in …

Objectives: Explain the evaluation of triple phosphate renal calculi. Review the management
options available for struvite and triple phosphate renal calculi. Outline the complications …

Purpose: Analyze the impact of tranexamic acid (TXA) use after percutaneous
nephrolithotomy (PCNL) on blood loss and transfusion rate (TR), and secondary outcomes …

Purpose: Bleeding is the most common percutaneous nephrolithotomy (PCNL) complication.
We investigated the role of tranexamic acid (TXA), which has numerous benefits in trauma …

Objective To assess the effects of tranexamic acid (TXA) in individuals with kidney stones
undergoing percutaneous nephrolithotomy (PCNL). Patients and Methods We performed a …